Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2005Clinical Cancer Research

Activated Epidermal Growth Factor Receptor–Stat-3 Signaling Promotes Tumor SurvivalIn vivoin Non–Small Cell Lung Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

EHEric B. HauraZZZhong ZhengLSLanxi Song

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Haura et al. (2005) studied this question.

synapsesocial.com/papers/69d8d0742c39562886ae2daehttps://doi.org/10.1158/1078-0432.ccr-05-0827
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells1999 · 119 citations
  2. 2Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer2005 · 1,568 citations
  3. 3Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer2004 · 747 citations
  4. 4Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study2005 · 585 citations